Univ.-Prof. Dr. med. Judit Simon, BA BSc MSc DPhil FFPH

Publications

2022

• Strube W, Aksar A, Bauer I, Barbosa S, Benros M, Blankenstein C, et al. Effects of add-on Celecoxib treatment on patients with schizophrenia spectrum disorders and inflammatory cytokine profile trial (TargetFlame): study design and methodology of a multicentre randomized, placebo-controlled trial. J Neural Transm. 2022 Nov. 19. DOI: 10.1007/s00702-022-02566-6
• Simon J. Methodological advancements in costing methods for (public) health economic evaluations: results from the European PECUNIA project. Eur J Public Health. 2022 Oct;32(S3):iii97. DOI: 10.1093/eurpub/ckac129.238
• Simon J, Wienand D, Park A-L, Wippel C, Mayer S, Heilig D, et al. Excess resource use and costs of physical comorbidities in patients with mental health disorders: A systematic review and meta analysis. Eur Neuropsychopharmacol. 2022 Nov 4;66:1-15. DOI: 10.1016/j.euroneuro.2022.10.001
• Łaszewska A,  Sajjad A, Busschbach J, Simon J, Hakkaart-van Roijen L. Conceptual framework for optimised proxy value set selection through supra-national value set development for the EQ-5D instruments. PharmacoEconomics. 2022 Dec;40(12):1221-1234. DOI: 10.1007/s40273-022-01194-y
• Middleton J, Davidovitch N, Barros H, Lopes H, Moreno JMM, Mason-Jones AJ, et al. ASPHER Statement: Planning for winter 2022-23. Public Health Rev. 2022 Oct 3;43:1605394. DOI:10.3389/phrs.2022.1605394
• Hrzic R, Davidovitch N, Barros H, Lopes H, Moreno JMM, Mason-Jones AJ,  et al. ASPHER Statement: Facing the fourth winter of the COVID-19 pandemic. Public Health Rev. 2022 Oct 3;43:1605395. DOI: 10.3389/phrs.2022.1605395
• Helter T, Laszewska A, Simon J. Exploring the over-time, multifaceted impacts of three Covid-19 lockdowns on aspects of capability, wellbeing and mental health across vulnerabilities in Austria. Sci Rep. 2022 Oct 01;2:16484. DOI: 10.1038/s41598-022-20977-z
• Economist Impact* (*Simon J). Depression in Europe: building resilience through raised awareness, improved access, integrated care and parity of esteem. 2022 Sep.
• Simon J, Kiss N, Korrelboom K, Kingdon D, Wykes T, Phiri P, et al. Cost-effectiveness of Positive Memory Training (PoMeT) for the treatment of depression in schizophrenia. Int J Environ Res Public Health. 2022 Sep 22;19(19):11985. DOI: 10.3390/ijerph191911985
• Gutierrez-Colosia M, Hinck P, Simon J, Konnopka A, Fischer C, Mayer S, et al. Magnitude of terminological bias in international health services research: a disambiguation analysis in mental health. Epidemiol Psychiatr Sci. 2022 Aug;31:e59. DOI:10.1017/S2045796022000403
• Fischer C, Mayer S, Perić N, Simon J. Harmonization issues in unit costing of service use for multi-country, multi-sectoral health economic evaluations: a scoping review. Health Econ Rev. 2022 Aug;12(1):42. DOI: 10.1186/s13561-022-00390-y
• Yildiz B, Allan S, Bakan M, Barnestein-Fonseca P,  Berger M, Boughey M, et al. Live well, die well – An international cohort study on experiences, concerns and preferences of patients in the last phase of life: The research protocol of the iLIVE study. BMJ Open. 2022 Aug;12:e057229. DOI: 10.1136/bmjopen-2021-057229
• Thorn J, Janssen L, Pokhilenko I, Berger M, Evers S MMA, Simon J. Conducting Think-Aloud Interviews Online: Development of a Recall Questionnaire in the PECUNIA Project. London: Sage Publications Ltd; 2022. DOI: 10.4135/9781529607475. ISBN: 9781529607475.
• Muntendorf L-K, König H-H, Janssen L, Pokhilenko I, Drost R, Simon J, et al. im Namen des PECUNIA Konsortiums. Kostensätze zur monetären Bewertung des Ressourcenverbrauchs psychischer Erkrankungen im Justizsektor: Ergebnisse des PECUNIA-Projekts für Deutschland. https://www.thieme-connect.com/products/ejournals/abstract/10.1055/a-1867-1458Gesundheitsökonomie & Qualitätsmanagment. 2022 Jul 13;
  DOI: 10.1055/a-1867-1458
• Helter TM, Łaszewska A, Stamm T, Coast J, Simon J. Comparison of capability and health-related quality of life instruments in capturing aspects of mental well-being in people with schizophrenia and depression. BJPsych Open. 2022 Jun 27;8(4):e117. DOI: 10.1192/bjo.2022.514
• Helter TM, Kaltenboeck A, Baumgartner J, Soennichsen A, Mayrhofer F, Heinze G, Wancata J, Simon J. Does the relative importance of the OxCAP-MH’s capability items differ according to mental ill-health experience? Health Qual Life Outcomes. 2022 Jun;20:99. DOI: 10.1186/s12955-022-02009-6
• Beccia F, Davidovitch N, McCallum A, Simon J, Reid J. How are inequalities in health from Long COVID being exacerbated and what are the strategic implications for more equitable support for those with enduring clinical sequelae of infection? ASPHER Statement. 2022 Jun.
• Tarantino S, Hiesmayr M, Sulz I and the nDay Working group. nutritionDay worldwide Annual Report 2019. Clin Nutr ESPEN. 2022 Jun;49:560-667. DOI: 10.1016/j.clnesp.2022.01.001
• Ilic L, Haidinger G, Simon J, Hackl M, Schernhammer E, Papantoniou K. Trends in female breast cancer incidence, mortality, and survival in Austria, with focus on age, stage, and birth cohorts (1983–2017). Sci Rep. 2022 Apr;12(1):7048. DOI: 10.1038/s41598-022-10560-x
• Laszewska A, Helter TM, Nagel A, Perić N, Simon J. Patient-reported outcome measures suitable for quality of life/wellbeing assessment in multi-sectoral, multi-national and multi-person mental health (economic) evaluations. Evid Based Ment Health. 2022 Apr;25:85-92. DOI:10.1136/ebmental-2021-300334
• Au-Yeung SK, Griffiths J, Roberts S, Edwards C, Yu LM, Bogacz R, et al. PAX-D: study protocol for a randomised placebo-controlled trial evaluating the efficacy and mechanism of pramipexole as add-on treatment for people with treatment resistant depression. Evid Based Ment Health. 2022 Apr;25:77-83. DOI:10.1136/ebmental-2021-300282
• Helter TM, Kaltenboeck A, Baumgartner J, Soennichsen A, Mayrhofer F, Heinze G, Wancata J, Simon J. Does the relative importance of the OxCAP-MH’s capability items differ according to mental ill-health experience? Research Square. 2022 Mar 2. DOI: 10.21203/rs.3.rs-1411909/v1
• Gervain J, Sz. Bartha K, B. Hodovánszky E, Kadlecsik L, Herczeg R, Gyenesei A, et al. Az anti-SARS-CoV-2-IgGantitest-immunválaszok monitorozása magyarországi egészségügyi dolgozók két kohorszában fertőzést, illetve immunizálást követően. Orv Hetil. 2022 Mar;163(12):455-462. DOI: 10.1556/650.2022.32467
• Mayer S, Berger M, Konnopka A, Brodszky V, Evers SMAA, Hakkaart-van Roijen L, et al. on behalf of the PECUNIA Group. In search for comparability: The PECUNIA reference unit costs for health and social care services in Europe. Int J Environ Res Public Health. 2022 Mar 16;19(6):3500. DOI:10.3390/ijerph19063500
• Sually D, Wong WL, Hidalgo-Mazzei D, Quoidbach V, Simon J, Boyer P, Strawbridge R, Young AH. The effects of COVID-19 on European healthcare provision for people with major depressive disorder: a scoping review protocol. medRxiv. 2022 Feb 19. DOI:10.1101/2022.02.17.22269638
• Reid J, Michelson K, Siepmann I, Mason-Jones A, Simon J. Addressing the long shadows of the COVID-19 pandemic's unjust, unequal, deep, widespread and enduring impacts over the next decade. 2nd ASPHER Statement on the pandemic impacts on health inequalities in disadvantaged vulnerable populations in the European region. 2022 Feb
• Fischer C, Mayer S, Perić N, Simon J on behalf of the PECUNIA Group. Establishing a comprehensive list of mental health-related services and resource use items in Austria: A national-level, cross-sectoral country report for the PECUNIA project. PLoS One. 2022 Jan 21;17(1):e0262091. DOI:10.1371/journal.pone.0262091
• Dillinger T, Sheibani-Tezerji R, Pulverer W, Stelzer I, Hassler MR, Scheibelreiter J, et al. Identification of tumor tissue-derived DNA methylation biomarkers for the detection and therapy response evaluation of metastatic castration resistant prostate cancer in liquid biopsies. Mol Cancer. 2022 Jan;21:7. DOI: 10.1186/s12943-021-01445-0

2021

• Lopes H, McCallum A, Reid J, Simon J, Wong B, Mason-Jones A, et al. "Covid-do-it-all". We need integrated protection systems and strategies against omicron and other COVID-19 variants. ASPHER Technical Report. 2021 Dec. p.12.
• Au-Yeung SK, Griffiths J, Roberts S, Edwards C, Yu LM, Bogacz R, et al. PAX-D: study protocol for a randomised placebo-controlled trial evaluating the efficacy and mechanism of pramipexole as add-on treatment for people with treatment resistant depression. Evid Based Ment Health. 2021 Nov 22;0:1-7. DOI:10.1136/ebmental-2021-300282
• Kiss N,  Hiesmayr M, Sulz I,  Bauer P,  Heinze G, Mouhieddine M, Schuh C, Tarantino S, Simon J. Predicting hospital length of stay at admission using global and country-specific competing risk analysis of structural, patient, and nutrition-related data from nutritionDay 2007-2015. Nutrients. 2021 Nov 16;13(11):4111. DOI: 10.3390/nu13114111
• Helter TM, Kovacs I, Kanka A, Varga O, Kalman J, Simon J. Internal and external aspects of freedom of choice in mental health: cultural and linguistic adaptation of the Hungarian version of the Oxford CAPabilities questionnaire—Mental Health (OxCAP-MH). BMC Psychol. 2021 Oct 18;9:161. DOI: 10.1186/s40359-021-00660-0
• Castelpietra G, Simon J, Gutiérrez-Colosía MR, Rosenberg S, Salvador-Carulla L. Disambiguation of psychotherapy: a search for meaning. BJPsych. 2021 Oct;219(4):532-537. DOI: 10.1192/bjp.2020.196
• Simon J, Anees AA, Wolstenholme J, Berger M, Goodwin GM, Geddes JR. The costs of bipolar disorder in the United Kingdom. Brain Behav. 2021 Oct;11(10):e2351. DOI: 10.1002/brb3.2351
• Sesa G, McCallum A, Martin-Moreno JM, Naboulet J-P, Green M, Davidovitch N, Simon J, Czabanowska K, Middleton J: Vaccinating Children and Young People: What are the issues? ASPHER statement. 2021 Sep 6.
• Łaszewska A, Helter TM, Simon J. Perceptions  of  Covid-19 lockdowns and related public health measures in Austria: a longitudinal online survey. BMC Public Health. 2021 Aug 4;21:1502. DOI: 10.1186/s12889-021-11476-3
• Simon J on behalf of the PECUNIA Consortium. Assessing the costs and outcomes of healthcare. EU Research (Spring 2021). 2021 Mar 23.
• Browning M, Bilderbeck A, Dias R, Dourish CT, Kingslake J, Deckert J, et al. The clinical effectiveness of using a predictive algorithm to guide antidepressant treatment in primary care (PReDicT): an open-label, randomised controlled trial. Neuropsychopharmacol. 2021 Jun;46(7):1307-1314. DOI: 10.1038/s41386-021-00981-z
• Gervain J, Szabo KB, Baki EH, Kadlecsik L, Gyenesei A, Herczeg R, Simon J. Monitoring of anti-SARS-CoV-2 IgG antibody immune response in infected and immunised healthcare workers in Hungary: a real-world longitudinal cohort study. medRxiv. 2021 May 17. DOI: 10.1101/2021.05.16.21257288
• Nagel A, Łaszewska A, Haidinger G, Simon J. The first 8 weeks of the Austrian SARS-CoV-2 epidemic. Wiener Klin Wochenschr. 2021 Apr;133(7):364-376. DOI: 10.1007/s00508-020-01804-9
• Katumba KR, Laurence YV, Tenywa P, Ssebunnya J, Laszewska A, Simon J, et al. Cultural and Linguistic Adaptation of the Multi-dimensional OXCAP-MH for Outcome Measurement in Mental Health among people living with HIV/AIDS in Uganda: The Luganda Version. J Patient Rep Outcomes. 2021 Apr 7;5:32. DOI: 10.1186/s41687-021-00306-0
• Moick S, Hiesmayr M,  Mouhieddine M, Kiss N, Bauere P, Sulz I, et al. Reducing the knowledge to action gap in hospital nutrition care – developing and implementing nutritionDay 2.0. Clin Nutr. 2021 Mar;40(3):936-945. DOI: 10.1016/j.clnu.2020.06.021
• Simon J, Helter T, White R, van der Boor C, Laszewska A. Impacts of the Covid-19 lockdown and relevant vulnerabilities on capability well-being, mental health and social support: An Austrian survey study. BMC Public Health. 2021 Feb 8;21:314. DOI:
  10.1186/s12889-021-10351-5
• Simon J, Mayer S, Laszewska A, Yeeles K, Burns T, Gray A. Cost and quality-of-life impacts of community treatment orders (CTOs) for patients with psychosis: Economic evaluation of the OCTET trial. Soc Psychiatry Psychiatr Epidemiol. 2021 Jan;56(1):85-95. DOI: 10.1007/s00127-020-01919-4
• Simon J. Psyche im Corona-Stress. Wien Wissen. 2021/1.

2020

• Stelzer IV, Sierawska A, Buyx A, Simon J. A network-based mixed methods approach to analyze current perspectives on personalized oncological medicine in Austria. J Pers Med. 2020 Dec 12;10(4),276. DOI: 10.3390/jpm10040276
• Brodszky V, Mayer S, Konnopka A, Evers SM, Hakkaart-van Roijen L, Salvador-Carulla L, et al. on behalf of the PECUNIA group. PNS 24 Standardized unit cost calculation for informal care time and cross-country comparison: PECUNIA Project Value Health. 2020 Dec;23(S2):S647-648. DOI: 10.1016/j.jval.2020.08.1468
• Simon J. COVID-19 in Austria. ASPHER Newsletter. 2020 Nov, p.10-15
• Simon J, Helter T, White R, van der Boor C, Laszewska A. Capability impacts of the Covid-19 lockdown in association with mental wellbeing, social connections and vulnerabilities. MedRxiv. 2020 Nov. DOI: 10.1101/2020.11.14.20231142
• Simon J, Konnopka A, Brodszky V, Evers SMAA, Hakkaart-van Roijen L, Serrano Aguilar PG, et al. (Pharmaco)economic evaluations for mental health related services: the PECUNIA project. Eur J Public Health. 2020 Sep 30;30(S5). DOI: 10.1093/eurpub/ckaa166.574
• Perić N, Ullmann T, Hofmarcher-Holzhacker MM, Or Z, Simon J. Is the EU ready for a generic set of indicators for health system performance? A qualitative study. Eur J Public Health. 2020 Sep 30;30(S5). DOI:10.1093/eurpub/ckaa166.498
• Steel C, Korrelboom K, Baksh K, Kingdon D, Simon J, Wykes T, Phiri P, Van der Gaag M. Positive Memory Training for the Treatment of Depression in Schizophrenia: a randomised controlled trial. Behav Res Ther. 2020 Dec;135:103734.  DOI: 10.1016/j.brat.2020.103734
• Mayer S, Fischer C, Zechmeister-Koss I, Ostermann H, Simon J. Are unit costs the same? A case study comparing different valuation methods for unit cost calculation of general practitioner consultations. Value Health. 2020 Sep 1;23(9):1142–1148. DOI: 10.1016/j.jval.2020.06.001
• Grössmann N, Robausch M, Willenbacher W, Wolf S, Simon J, Wild C. Magnitude of Clinical Benefit” of solid tumour drugs and their real-world application in the Austrian health care setting. J Cancer Policy. 2020 Sep;25:100235. DOI: 10.1016/j.jcpo.2020.100235
• Łaszewska A, Wancata J, Jahn R, Simon J. The excess economic burden of mental disorders: findings from a cross-sectional prevalence survey in Austria. J Health Econ. 2020 Sep;21: 1075–1089. DOI: 10.1007/s10198-020-01200-0
• Pokhilenko I, Janssen L, Evers S, Drost R, Simon J, König H-H, et al. Exploring the identification, validation, and categorization of costs and benefits of education in mental health: The PECUNIA project.  Int J Technol Assess Health Care. 2020 Aug;36(4):325-331. DOI: 10.1017/S0266462320000203
• Janssen L, Pokhilenko I, Evers S, Drost R, Simon J, König H-H, et al. on behalf of the PECUNIA Group. Exploring the Identification, Validation and Categorization of Cost & Benefits of Criminal Justice in Mental Health: the PECUNIA Project. Int J Technol Assess Health Care. 2020 Aug;36(4):418-425.
  DOI:10.1017/S0266462320000471
• Simon J, Mayer S, Laszewska A, Yeeles K, Burns T, Gray A. Cost and quality-of-life impacts of community treatment orders (CTOs) for patients with psychosis: Economic evaluation of the OCTET trial. Soc Psychiatry Psychiatr Epidemiol. 2020 Jul 27. DOI: 10.1007/s00127-020-01919-4
• Simon J, Perić N, Mayer S, Deckert J, Gorwood P, Pérez V, et al. on behalf of the PReDicT group. Cost-effectiveness of the predict test: results and lessons learned from a european multinational depression trial. EPP0934. Eur Psychiatry. 2020 Jul;63(S1):S45-S282. DOI: 10.1192/j.eurpsy.2020.5
• Simon J, Konnopka A, Brodszky V, Evers SMAA, Hakkaart-van Roijen L, Serrano Aguilar PG, et al. (Pharmaco)economic evaluations for mental health related services: the PECUNIA project. EPP1010. Eur Psychiatry. 2020 Jul; 63(S1):S45-S282. DOI: 10.1192/j.eurpsy.2020.5
• Simon J, Wienand D, Park A-L, Goodwin G, Mcdaid D. The excess resource use and costs of physical comorbidities in patients with mental health disorders. EPP 0307. Eur Psychiatry. 2020 Jul; 63(S1):S45-S282. DOI: 10.1192/j.eurpsy.2020.5
• Hiesmayr M, Tarantino S, Moick S, Laviano A, Sulz I, Mouhieddine M, et al. Hospital Malnutrition, a Call for Political Action: A Public Health and NutritionDay Perspective. In: Stanga Z, Schuetz P, editors. Nutritional Management and Outcomes in Malnourished Medical Inpatients. JCM. 2020 Jul;Special Issue:5-22. ISBN 978-3-03936-491-6 (Hbk); ISBN 978-3-03936-492-3 (PDF), DOI: 10.3390/books978-3-03936-492-3
• Steel C, Wright K, Goodwin G, Simon J, Morant J, Taylor J, et al. The IBER study: study protocol for a feasibility randomised controlled trial of Imagery Based Emotion Regulation for the treatment of anxiety in bipolar disorder. Pilot Feasibility Stud. 2020 Jun 15; 6:83. DOI: 10.1186/s40814-020-00628-8
• Helter TM, Coast J, Łaszewska A, Stamm T , Simon J. Capability instruments in economic evaluations of health-related interventions: a comparative review of the literature. Qual Life Res, 2020 Jun;29(6):1433–1464. DOI:10.1007/s11136-019-02393-5
• Fischer C, Chwala E, Simon J. Methodological aspects of economic evaluations conducted in the palliative or end of life care settings: a systematic review protocol. BMJ Open. 2020 May 27;10(5):e035760. DOI:10.1136/bmjopen-2019-035760
• Simon J. Health economic analysis of service provision. (Chapter 23/136) In: Geddes JR, Andreasen NC, Goodwin GM. New Oxford Textbook of Psychiatry. 3rd ed. Oxford: Oxford University Press; 2020. ISBN: 9780198713005
• Grössmann N, Robausch M, Rothschedl E, Wild C, Simon J.  Publicly accessible evidence of health-related quality of life benefits associated with cancer drugs approved by the European Medicines Agency between 2009 and 2015. Eur J Cancer. 2020 Apr;129:23-31. DOI: 10.1016/j.ejca.2020.01.020v
• Lim MS, Beyer T, Babayan A, Bergmann M, Brehme M, Buyx A, et al. Advancing Biomarker Development Through Convergent Engagement: Summary Report of the 2nd International Danube Symposium on Biomarker Development, Molecular Imaging and Applied Diagnostics; March 14-16, 2018; Vienna, Austria. Mol Imaging Biol. 2020 Feb;22:47-65. DOI: 10.1007/s11307-019-01361-2
• Moick S, Simon J, Hiesmayr M. Nutrition care quality indicators in hospitals and nursing homes: A systematic literature review and critical appraisal of current evidence. Clin Nutr. 2020;39(6):1667-1680. DOI:10.1016/j.clnu.2019.07.025

2019

• Simon J, Perić N, Mayer S, Deckert J, Gorwood P, Pérez V, Reif A, Ruhe H, Veltman D, Morriss R, Bilderbeck A, Dawson G, Dourish C, Dias R, Kingslake J, Browning M, on behalf of the PReDicT group  (2019) PMH21 Cost-effectiveness of the Predict Test: Results and Lessons learned from a European Multinational Depression Trial  Value in Health, 22, S684. DOI: 10.1016/j.jval.2019.09.1495
• Hiesmayer M, Tarantino S, Moick S, Laviano A, Sulz I, Mouhieddine M, Schuh C, Volkert D, Simon J, Schindler K (2019) Hospital malnutrition, a call for political action: a public health and nutritionDay perspective. Journal of Clinical Medicine, 8 (12). doi: 10.3390/jcm8122048
• Kiss N, Sulz I, Bauer P, Simon J, Mouhieddine M, Hiesmayr J M (2019) Nutrition-Related Factors Associated with Length of Hospital Stay Following NutritionDay, Clinical Nutrition, Vol 38, Suppl 1, p 18, DOI: 10.1016/S0261-5614(19)32510-5
• Simon J, Harmer CJ, Kingslake J, Dawson GR, Colin T D, Goodwin GM. The value of monitoring negative emotional bias in primary care in England for personalised antidepressant treatment: A modelling study. Evidence Based Mental Health. doi:10.1136/ebmental-2019-300109
• Wienand D, Park A-La, Wippel C, Laszewska A, Stelzer IV, Mayer S, Goodwin G, McDaid D, Simon J (2019) The Excess Costs and Resource Use of Physical Comorbidities in Patients with Mental Health Disorders: A Systematic Review. The Journal of Mental Health Policy and Economics, 22 (Suppl 1), p 36.
• Simon J, Laszewska A, Oberrauter M, Schwab M, Mayer S, Churchman D, Spiel G (2019) Is the Oxcap-Mh Capability Measure a Feasible and Psychometrically Valid Tool for the Routine Evaluation of Mental Health Services? Value in Health, Vol 22, p 690, DOI: 10.1016/j.jval.2019.09.1528
• Moick S, Simon J, Hiesmayr M (2019) Nutrition care quality indicators in hospitals and nursing homes: A systematic literature review and critical appraisal of current evidence. Clinical Nutrition, 39, pp 1667-1680, doi.org/10.1016/j.clnu.2019.07.025
• Fischer C, Mayer S, Peric N, Simon J (2019) Valuation Methods in Costing for International, Multi-Sectoral Mental Health Economic Evaluations: A Structured Scoping Review. The Journal of Mental Health Policy and Economics, 22(Suppl 1), p 9.
• Pokhilenko I, Janssen LMM, Paulus ATG, Drost RMWA, Simon J, König HH, Brodszky V, Salvador-Carulla L, Park AL, Evers AMAA (2019) Inter-sectoral Costs and Benfits of Mental Health Intervention within Educational Sector. The Journal of Mental Health Policy and Economics, 22(Suppl 1), p 28
• Janssen LMM, Pokhilenko I, Drost RMWA, Paulus ATG, Brodzky V, Park AL, König HH, Salvador-Carulla L, Simon J (2019) Inter-sectoral Costs and Benefits within Crimincal Justice. The Journal of Mental Health Policy and Economics, 22(Suppl 1), p15.
• Brodszky V, Gulácsi L, Netshiombo M, Rasdan O, Evers S, König H-H, Park A-L, Salvador-Carulla L, Simon J (2019) Costs Incurred in the Household of Schizophrenic Patients: A Systematic Review. The Journal of Mental Health Policy and Economics, 22(Suppl 1), p4.
• Simon J, König H-H, Brodszky V, Hakkaart-van Roijen L, Serrano Aguilar PG, Salvador-Carulla L, Park A-L, Hollingworth W, Schneider V on behalf of the PECUNIA Group (2019) Inter-sectoral Costs and Benefits of Mental Care in Europe: European Research Project PECUNIA. The Journal of Mental Health Policy and Economics, 22(Suppl 1), p 32.
• Prevolnik Rupel V, Divjak M, Zrubka Z, Rencz F, Gulácsi L, Golicki D, Mirowska-Guzel D, Simon J, Brodszky V, Baji P, Závada J, Petrova G, Rotar A, Péntek M (2019) EQ-5D studies in nervous system diseases in eight Central and East European countries: a systematic literature review. The European Journal of Health Economics, 20(Suppl 1):109-117 DOI: 10.1007/s10198-019-01068-9
• Brodszky V, Beretzky Z, Baji P, Rencz F, Péntek M, Rotar A, Tachkov K, Mayer S, Simon J, Niewada M, Hren R, Gulacsi L (2019) Cost-of-illness studies in Central and Eastern European countries. European Journal of Health Economics, 20 (Suppl 1):155–172. doi: 10.1007/s10198-019-01066-x
• Simon J (2019) Ökonomische Konsequenzen. In: Novotny, M, Kern, D, Breyer, E, Bengough, T, Griebler, R (Hg.): Depressionsbericht Österreich. Eine interdisziplinäre und multiperspektivische Bestandsaufnahme. Bundesministerium für Gesundheit und Frauen (BMGF): Wien, pp 135-141.
• Lim MS, Beyer T, Babayan A, Bergmann M, Brehme M, Buyx A, Czernin J, Egger G, Elenitoba-Johnson KSJ, Gückel B, Jačan A, Haslacher H, Hicks RJ, Kenner L, Langanke M Mitterhauser M, Pichler BJ, Salih HR, Schibli R, Schulz S, Simecek J, Simon J, Soares MO, Stelzl U, Wadsak W, Zatloukal K, Zeitlinger M, Hacker M (2019) Advancing Biomarker Development Through Convergent Engagement: Summary Report of the 2nd International Danube Symposium on Biomarker Development, Molecular Imaging and Applied Diagnostics; March 14-16, 2018; Vienna, Austria. Molecular Imaging and Biology, Special Topic, pp 1-19. DOI: 10.1007/s11307-019-01361-2
• Łaszewska A, Schwab M, Leutner E, Oberrauter, M, Spiel, G, Simon, J (2019) Measuring broader wellbeing in mental health services: validity of the German language OxCAP-MH capability instrument. Quality of Life Research: 28(8):2311-2323, DOI:10.1007/s11136-019-02187-9
• Mayer S, Spickschen J, Stein KV, Crevenna R, Dorner TE, Simon J (2019) The societal costs of chronic pain and its determinants: the case of Austria. PLoS ONE, 14(3):e0213889. DOI: doi.org/10.1371/journal.pone.0213889
• Dawson GR, Guo B, Kingslake J, Ruhe HG, Veltman D, Deckert J, Reif A., Gorwood P, Perez V, Simon J, Harmer CJ, Goodwin GM, Dias R, Dourish CT, Bilderbeck AC, Pearce L, Campbell S, Morriss R, Browning M (2019) Results of the predict randomised controlled trial: clinical effects of using the predict test to guide antidepressant treatment in depression. European Neuropsychopharmacology, Vol 29, Suppl 6,  pp S53-S54, DOI: 10.1016/j.euroneuro.2019.09.112
• Grössmann N,  Robausch M,  Rosian K, Wild C, Simon J (2019) Monitoring evidence on overall survival benefits of anti-cancer drugs approved by the European Medicines Agency between 2009 and 2015. European Journal Of Cancer. European Journal of Cancer. (110): 1-7. DOI: 10.1016/j.ejca.2018.12.026
• Cheung KL, Mayer S, Simon J, de Vries H, Evers S, Kremer I, Hiligsmann M (2019) Comparison of statistical analysis methods for object case best-worst scaling. Journal of Medical Economics, 22(6):509–515. doi.org/10.1080/13696998.2018.1553781
• Simon J. S.09.03 Better prediction of outcomes in depression what kind of societal impact can we expect?, Eur Neuropsychopharm. 2019;29(S1):S13. DOI: 10.1016/j.euroneuro.2018.11.933

2018

• Simon J, Geddes JR, Gardiner A, Rendell J, Goodwin GM, Mayer S (2018) Comparative economic evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in patients with bipolar depression (CEQUEL). Bipolar Disorder. 20(8):733-745. doi.org/10.1111/bdi.12713
• Niedersüß-Beke D, Simon J, Schiffinger M, Mader RM (2018) Economic analysis of biomarker-based anti-EGFR therapies in metastatic colorectal cancer in the Austrian context. MEMO Magazine of European Medical Oncology, (11: 322), 1-8. doi: 10.1007/s12254-018-0440-y  
• Perić N, Hofmarcher-Holzhacker M M, Simon J (2018) Headline indicators for monitoring the performance of health systems: Findings from the european Health Systems_Indicator (euHS_I) survey. Archives of Public Health. 76: 32. doi:  10.1186/s13690-018-0278-0
• Köppen P, Dorner T, Stein K, Simon J, Crevenna R (2018) Health literacy, pain intensity and pain perception in patients with chronic pain. Wiener Klinischen Wochenschrift, 130(1): 23–30. DOI: 10.1007/s00508-017-1309-5
• Simon J, Łaszewska A, Leutner E, Spiel G, Churchman D, Mayer S (2018) Cultural and linguistic transferability of the multi-dimensional OxCAP-MH capability instrument for outcome measurement in mental health: the German language version. BMC Psychiatry, 18(1):173.
• Batóg P, Rencz F, Péntek M, Gulácsi L, Filipiak KJ, Prevolnik Rupel V, Simon J, Brodszky V, Baji P, Závada J, Petrova G, Rotar A, Golicki D (2018) EQ-5D studies in cardiovascular diseases in eight Central and Eastern European countries: a systematic review of the literature. Kardiol Pol. 2018 Jan 19. doi: 10.5603/KP.a2018.0033. [Epub ahead of print] PubMed PMID: 29350378
• Łaszewska A, Österle A, Wancata J, Simon J (2018) Prevalence of mental diseases in Austria: systematic review of the published evidence. Wiener Klinische Wochenschrift, 130(3-4): 141-150. DOI: 10.1007/s00508-018-1316-1

2017

• Simon J (2018): Public Health Economics: Gesundheitsökonomie zur Gesundheitsförderung und Krankheitsvorbeugung. Gesundheit 2017. Jahrbuch für Gesundheitspolitik und Gesundheitswirtschaft in Österreich. Sanofi 2017, 9. Ausgabe, Pages 64-65.
• Feig C, Cheung KL, Hiligsmann M, Evers S, Simon J, Mayer S (2018) Best-worst scaling to assess the most important barriers and facilitators for the use of Health Technology Assessment in Austria. Expert Review of Pharmacoeconomics & Outcomes Research. 18(2), 223-232.
• Hofmarcher MM, Perić N, Simon J. (2017) Headline indicators for structured monitoring of health system performance in Europe. Eurohealth, 23(4): 11-15
• Vergunst F, Jenkinson C, Burns T, Anand P, Gray A, Rugkåsa J, Simon J (2017) Psychometric validation of a multi-dimensional capability instrument for outcome measurement in mental health research (OxCAP-MH). Health and Quality of Life Outcomes, 15:250. DOI: 10.1186/s12955-017-0825-3
• Simon J, Łaszewska A, Leutner E, Churchman D, Mayer S (2017) Inter-country Transferability of the OxCAP-MH Well-being Questionnaire. J Ment Health Policy Econ 2017; 20(Suppl. 1): S31
• Kingslake J, Dias R, Dawson GR, Simon J, Goodwin GM, Harmer CJ, et al. (2017) The effects of using the PReDicT Test to guide the antidepressant treatment of depressed patients: Study Protocol for a Randomised Controlled Trial. Trials. DOI: 10.1186/s13063-017-2247-2
• Vergunst F, Rugkåsa J, Koshiaris C, Simon J, Burns T (2017) Community treatment orders and social outcomes for patients with psychosis: a 48-month follow-up study. Social Psychiatry and Psychiatric Epidemiology, 52(11), 1375-1384, Nov 2017. DOI: 10.1007/s00127-017-1442-5
• Zrubka Z, Rencz F, Závada J, Golicki D, Prevolnik Rupel V, Simon J, Brodszky V, Baji P, Petrova G, Rotar A, Gulácsi L, Péntek M (2017) EQ-5D studies in musculoskeletal and connective tissue diseases in eight Central and Eastern European countries: a systematic literature review and meta-analysis. Rheumatology International, 37(12), 1957–1977, Dec 2017. DOI: 10.1007/s00296-017-3800-8
• Mayer S, Kiss N, Łaszewska A, Simon J (2017) Costing evidence for health care decision-making in Austria: A systematic review. PLOS ONE, 12(8): e0183116. DOI: 10.1371/journal.pone.0183116.
• Hofmarcher M M, Simon J, Haidinger G (2017) Stroke-units in Austria: incubators for improved health outcomes. in Braithwaite J. et al (Ed) Health Systems Improvement Across the Globe: Success Stories from 60 Countries, CRC Press.
• Simon J, Budge K, Price J, Goodwin G M, Geddes J R (2017) Remote mood monitoring for adults with bipolar disorder: an explorative study of compliance and impact on mental health service use. European Psychiatry, 45C, pp. 14-19. DOI: 10.1016/j.eurpsy.2017.06.007. 
• Mayer S, Paulus A, Łaszewska A, Simon J, Drost R, Ruwaard D, Evers S. (2017) Health-related resource-use measurement items for intersectoral costs and benefits (ICBs) in the education and criminal justice sector: systematic review of instruments. PharmacoEconomics, 35(9), 895-908. DOI: 10.1007/s40273-017-0522-4.
• Bogaert P, Van Oyen H for BRIDGE Health (Hofmarcher M M, Simon J, Perić N) (2017) HIREP-ERIC: A research infrastructure to advance public health monitoring and research on health and care. Technical and Scientific Description, BRIDGE Health Technical Report 03/2017, Scientific Institute of Public Health, Brussels, March 2017.
• Bogaert P, Van Oyen H for BRIDGE Health (Hofmarcher M M, Simon J) (2017) An ERIC on Health Information for Research and Evidence-based Policy for targeted investments in people's health and wealth, BRIDGE Health policy paper, Scientific Institute of Public Health, Brussels, January 2017.
• Hofmarcher-Holzhacker M, Perić N, Simon J (2017) Schlüsselindikatoren für eine strukturierte Bewertung der Leistungsfähigkeit von Gesundheitssystemen in Europa: ein Fortschrittsbericht des EU Projekts BRIDGE Health. ÖGPH Newsletter March 2017
• Hofmarcher M M, Perić N, Simon J on behalf of the BRIDGE Health working group for horizontal activity 6 (2017) Priority setting methods in health information, BRIDGE Health Technical Report 04/2017 on Recommendations of priority setting methods for a European Research Infrastructure Consortium on Health Information for Research and Evidence-based policy (HIREP-ERIC), HS&I and Medical University of Vienna, April 2017.
• Perić N, Hofmarcher-Holzhacker M M, Simon J (2017) Health system performance assessment landscape at the EU level: A focused synthesis of actors and actions. Archives of Public Health, 75(5). DOI: 10.1186/s13690-016-0173-5.

2016

• Hofmarcher M M, Perić N, Simon J, Joas A, Bogaert P (2016) Priority setting methods and transferability in health information. Adjacent Government.
• Hofmarcher MM, Simon J, Perić N, Or Z, Smith P, Busse R, van Oyen H, on behalf of BRIDGE Health. (2016) Priority setting methods in health information: MM Hofmarcher. The European Journal of Public Health, 26(suppl_1), ckw169-076. doi.org/10.1093/eurpub/ckw169.076
• Burns T, Rugkåsa J, Yeeles K, Catty J, on behalf of the Oxford Mental Health Coercion (OCTET) Programme Group (Simon J) (2016) Coercion in mental health: a trial of the effectiveness of community treatment orders and an investigation of informal coercion in community mental health care. Programme Grants Appl Res, 4(21). DOI: 10.3310/pgfar04210.
• Mayer S, Vogler S, Simon J, Österle A. Exploring determinants of polypharmacy in the elderly population in Austria. Value in Health, Volume 19, Issue 7, November 2016, Page A451
• Mayer S, Kiss N, Łaszewska A, Simon J. Health Economic Costing Methods and Reporting in Austria. Value in Health, Volume 19, Issue 7, November 2016, Page A363
• Golicki D, Péntek M, Gulácsi L, Prevolnik Rupel V, Simon J, Brodszky V, Baji P, Zrubka Z, Závada J, Petrova G, Rotar A, Rencz F. EQ-5D Studies in Diseases of The Circulatory System in Eight Central and Eastern European Countries. Value in Health, Volume 19, Issue 7, November 2016, Pages A657-A658
• Péntek M, Rencz F, Golicki D, Prevolnik Rupel V, Simon J, Brodszky V, Baji P, Závada J, Zrubka Z, Petrova G, Rotar A, Gulácsi L. EQ-5D Studies in Rheumatology in Eight Central and Eastern European Countries. Value in Health, Volume 19, Issue 7, November 2016, Page A542
• Prevolnik Rupel V, Turk E, Péntek M, Rencz F, Golicki D, Simon J, Brodszky V, Baji P, Zrubka Z, Zavada J, Petrova G, Rotar A, Gulacsi L. Eq-5d Studies In Nervous System Diseases In Eight Central And Eastern European Countries. Value in Health, Volume 19, Issue 7, November 2016, Page A471
• Bilderbeck AC, Atkinson LZ, McMahon HC, Voysey M, Simon J, Price J, Rendell J, Hinds C, Geddes JR, Holmes E, Miklowitz DJ, Goodwin GM (2016) Psychoeducation and online mood tracking for patients with bipolar disorder: A randomised controlled trial. Journal of Affective Disorders, 205:245-251. DOI: 0.1016/j.jad.2016.06.064.
• Rencz F, Gulácsi L, Drummond M, Golicki D, Prevolnik Rupel V, Simon J, Stolk EA, Brodszky V, Baji P, Závada J, Petrova G, Rotar A, Péntek M (2016) EQ-5D in Central and Eastern Europe: 2000-2015. Quality of Life Research, 19(5):525-530. DOI: 10.1007/s11136-016-1375-6
• Barnes TRE, Leeson VC, Paton C, Costelloe C, Simon J, Kiss N, Osborn D, Killaspy H, Craig TKJ, Lewis S, Keown P, Ismail S, Crawford M, Baldwin D, Lewis G, Geddes J, Kumar M, Pathak R, Taylor S (2016) Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial. Health Technology Assessment, 20(29). DOI: 10.3310/hta20290.
• Geddes J, Gardiner A, Rendell J, Voysey M, Tunbridge E, Hinds C, Yu L-M, Hainsworth J, Attenburrow M-J, Simon J, Goodwin G, Harrison P (2016) Comparative evaluation of quetiapine-lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression: a 2x2 factorial randomised trial (CEQUEL). The Lancet Psychiatry, 3(1):31–39. DOI: 10.1016/S2215-0366(15)00450-2.
• Simon, J. (2016). Determinanten von Gesundheit und Gesundheitsversorgung. In: Dorner, T.E. (ed.). Public Health. Von den Gesundheitsbedürfnissen der Gesellschaft zu klinischen Implikationen. MCW Block 22/23. Facultas Verlags- und Buchhandels AG: 4. Auflage, Wien
• Simon, J. (2016). Gesundheitsökonomische Evaluation II. In: Dorner, T.E. (ed.). Public Health. Von den Gesundheitsbedürfnissen der Gesellschaft zu klinischen Implikationen. MCW Block 22/23. Facultas Verlags- und Buchhandels AG: 4. Auflage, Wien

2015

• Simon, J (2015). Determinanten von Gesundheit und Gesundheitsversorgung. In: Dorner, T.E. (ed.). Public Health. Von den Gesundheitsbedürfnissen der Gesellschaft zu klinischen Implikationen. MCW Block 22/23. Facultas Verlags- und Buchhandels AG: 3. Auflage, Wien
• Simon, J (2015). Gesundheitsökonomische Evaluation II. In: Dorner, T.E. (ed.). Public Health. Von den Gesundheitsbedürfnissen der Gesellschaft zu klinischen Implikationen. MCW Block 22/23. Facultas Verlags- und Buchhandels AG: 3. Auflage, Wien
• Rugkåsa J, Molodynski A, Yeeles K, Vazquez Montes M, Visser C, Burns T, Bennett C and the OCTET group (Burns K, Burns T, Canvin K, Dawson J, Dunn M, Gray A, Johnston L, Lewis N, Masson S, Molodynski A, Murray L, Nightingale H, Patel R, Priebe S, Puntis S, Russell L, Ryan A, Simon J, Sinclair J, Smith T, Sulman A, Turnpenny L, Mitchell A, Montes MV, Vergunst F, Visser C, Wood-Ganz S, Voysey M, Yeeles K) (2015) Community treatment orders: Clinical and social outcomes, and a subgroup analysis from the OCTET RCT. Acta Psychiatrica Scandinavia, 131(5):321-329. DOI 10.1111/acps.12373
• Pari AA, Simon J, Wolstenholme J, Geddes J, Goodwin G (2015) Economic burden of bipolar disorder in the United Kingdom: a patient-level exploratory analysis. Bipolar Disorders, 17:138.
• Hofmarcher-Holzhacker M, Simon J, Peric N (2015) Kick off neue Projekte - BRIDGE Health: Bridging Information and Data Generation for Evidence-based Health Policy and Research. ÖGPH Newsletter September 2015, pp. 11-12.
• Simon J, Kiss N, Łaszewska A, Mayer S (2015) Public health aspects of migrant health: a review of the evidence on health status for labour migrants in the European Region. WHO Health Evidence Network Synthesis Report 43. ISBN 978 92 890 5109 5
• Simon J, Gray A, Mayer S, Ł aszewska A, Rugkåsa J, Yeeles K, Burns T (2015) Cost-effectiveness of Community Treatment Orders (CTOs): Economic Evaluation of the OCTET Study. Journal of Mental Health Policy and Economics, 18 (S1): S36.
• Steel C, van der Gaag M, Korrelboom K, Simon J, Phiri P, Baksh M F, Wykes T, Rose D, Rose S, Hardcastle M, Enright S, Evans G, Kingdon D (2015) A randomised controlled trial of positive memory training for the treatment of depression within schizophrenia, BMC Psychiatry 15:85 doi:10.1186/s12888-015-0453-6.
• Simons CL, Rivero-Arias O, Yu LM, Simon J (2015) Multiple imputation to deal with missing EQ-5D-3L data - should we impute individual domains or the actual index?, Quality of Life Research, doi: 10.1007/S11136-014-0837-Y

2014

• Vergunst F, Jenkinson C, Burns T, Simon, J (2014) Application of Sen's Capability Approach to Outcome Measurement in Mental Health Research: Psychometric Validation of a Novel Multi-dimensional Instrument (OxCAP-MH). Human Welfare 3, 1, 1-4.
• Abdul Pari Anees A, Simon J, Wolstenholme J, Geddes JR, Goodwin GM (2014) Economic evaluations in bipolar disorder: a systematic review and critical appraisal. Bipolar Disorders, Volume 16, Issue 6, pages 557–582. doi: 10.1111/bdi.12213.

2013 and before

• Simon J, Anand P, Gray A, Rugkåsa J, Yeeles K, Burns T (2013) Operationalising the capability approach for outcome measurement in mental health research Social Science & Medicine, 98:187–196. doi: 10.1016/ j.socscimed.2013.09.019
• Miklowitz DJ, Price J, Holmes EA, Rendell J, Bell S, Budge K, Christensen J, Wallace J, Simon J, Armstrong NM, McPeake L, Goodwin GM, Geddes JR (2012) Facilitated Integrated Mood Management for adults with bipolar disorder. Bipolar Disorder Mar 2012; 14(2): 185–197. doi:  10.1111/j.1399-5618.2012.00998.x
• Simon J, Budge KV, Goodwin G, Geddes J (2011) Health economic preparatory work for OXTEXT: The development and evaluation of cost-effective systems of collaborative disease management for people with bipolar disorder. Journal of Mental Health Policy and Economics, 14(Suppl.1): S32.
• Farmer A J, Wade A N, French D P, Simon J, Yudkin P, Gray A, Craven A, Goyder L, Holman R R, Mant D, Kinmonth A-L, Neil H AW (2009) Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial. Health Technol Assess. 2009 Feb;13(15):iii-iv, ix-xi, 1-50. doi: 10.3310/hta13150.
• Simon J, Petrou S, Gray A. (2009) The valuation of prenatal life in economic evaluations of perinatal interventions. Health Economics, 18(4): 487-494.
• Simon J, et al. (2009) A vércukorszint otthoni monitorozásának költséghatékonysága 2-es típusú cukorbetegségben. Lege Artis Medicinae, 19(1): 45.
• Simon J, Gray A, Wade A, Neil A, Farmer A, on behalf of the Diabetes Glycaemic Education and Monitoring Trial Group (2008) Cost-effectiveness of self-monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial. British Medical Journal, 336: 1177-1180. doi: 10.1136/bmj.39526.674873.BE
• Zechmeister I, Kilian R, McDaid D, the MHEEN group (2008) Is it worth investing in mental health promotion and prevention of mental illness? A systematic review of the evidence from economic evaluations. BMC Public Health, 8: 20.
• Knapp M, McDaid D, Evers S, Salvador-Carulla L, Halstein V, the MHEEN group (2008) Cost-effectiveness and Mental Health, MHEEN II Policy Briefing 2, Personal Social Services Research Unit, London.
• McDaid D, Knapp M, Medeiros H, the MHEEN group (2008) Employment and Mental Health: Assessing the Economic Impact and the Case for Intervention, MHEEN II Policy Briefing 5. Personal Social Services Research Unit, London.
• McDaid D, Zechmeister I, Kilian R, Medeiros H, Knapp M, Kennelly B, the MHEEN group (2008) Making the Economic Case for the Promotion of Mental Well-being and the Prevention of Mental Health Problems, MHEEN II Policy Briefing 3. Personal Social Services Research Unit, London.
• Medeiros H, McDaid D, Knapp M, the MHEEN group (2008) Shifting Care from Hospital to the Community in Europe: Economic Challenges and Opportunities, MHEEN II Policy Briefing 4. Personal Social Services Research Unit, London.
• Knapp M, McDaid D, Medeiros H, Becker T, Johnson S, Kilian R, Salvador-Carulla L, Simon J, Tatar M, on behalf of the MHEEN group (2008) Economics, Mental Health and Policy: An Overview, MHEEN II Policy Briefing 1. Personal Social Services Research Unit, London.
• MAGPIE Trial Follow Up Study Collaborative Group (2007) The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for children at 18 months. BJOG-INT J OBSTET GY, 114(3): 289-299.
• MAGPIE Trial Follow Up Study Collaborative Group (2007) The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for women at 2 years. BJOG-INT J OBSTET GY, 114(3): 300-309.
• McDaid D, Knapp M, Medeiros H, the MHEEN group (2007) Mental health and economics in Europe. Findings from the MHEEN group. Eurohealth, 13(3): 1-6.
• Simon J, Gray A, Wade A, et al. (2007) Cost-effectiveness of self-monitoring of blood glucose for the management of patients with non-insulin treated type 2 diabetes: economic evaluation of the DiGEM trial. Diabetologia, 50(Suppl.1): S431.
• Simon J, Pilling S, Goldberg D, Burbeck R (2006) Treating moderate and severe depression with antidepressant therapy or combination of antidepressants and psychological therapy: a decision analysis supporting a clinical guideline. British Journal of Psychiatry, 189: 494-501.
• Clarke PM, Simon J, Cull CA, Holman RR (2006) Assessing the impact of visual acuity on quality of life in people with type 2 diabetes using the SF-36. Diabetes Care, 29: 1506-1511.
• Simon J, Gray A, Duley L, on behalf of the MAGPIE Trial Collaborative Group (2006) Cost effectiveness of prophylactic magnesium sulphate in 9996 women with pre-eclampsia from 33 countries: Economic evaluation of the Magpie Trial. BJOG, 113: 144-151.
• Gervain J, Simon J, Czibula A, et al. (2006) The correlation of genom mutations in HCV-1b with IFN-sensitivity in Hungarian patients. Journal of Gastroenterology and Hepatology, 21(Suppl.2): A139-A139.
• Simon J, Patel A, Sleed M (2005) The costs of alcoholism. Journal of Mental Health, 14(4): 321-330.
• Simon J, Schmidt U, Pilling S, on behalf of the Eating Disorders Guideline Development Group (2005) The health service use and cost of eating disorders. Psychological Medicine, 35(11): 1543-1551.
• National Collaborating Centre for Mental Health (2004) Depression: management of depression in primary and secondary care. Clinical Guideline 23. NICE: London.
• Knapp M, Mangalore R, Simon J (2004) The global costs of schizophrenia. Schizophrenia Bulletin, 30: 279-293.
• Petrou S, Boulvain M, Simon J, Maricot P, Borst F, Irion O (2004) Home-based care after a shortened hospital stay versus hospital-based care postpartum: An economic evaluation. BJOG, 111: 800-806.
• National Collaborating Centre for Mental Health (2004) Eating disorders: Core interventions in the treatment and management of anorexia nervosa, bulimia nervosa and related eating disorders. Clinical Guideline 9. NICE: London.
• National Collaborating Centre for Mental Health (2004) Depression: management of depression in primary and secondary care. National Clinical Practice Guideline CG23. Gaskell Press: London.
• Richardson G, Wonderling D, Simon J, Wailoo A, Douglas HR, Culyer AJ, Tsuchiya A, Roberts J, Drummond MF, on behalf of the Health Economists in Guidelines group (2004) Incorporating health economics in guidelines and assessing resource impact. In: NICE. Guideline development methods: Information for National Collaborating Centres and Guideline Developers. NICE: London.  
• National Collaborating Centre for Mental Health (2004) Eating disorders: Core interventions in the treatment and management of anorexia nervosa, bulimia nervosa and related eating disorders. National Clinical Practice Guideline CG9. Gaskell Press: London.
• Gervain J, Simon G, Simon J, the Hungarian Viral Hepatitis Group (2003) Genotype distribution of hepatitis C virus in the Hungarian population with chronic viral hepatitis C. European Journal of Gastroenterology and Hepatology, 15(4): 449-450.
• Gervain J, Czibula A, Simon J, Kalmar T (2003) Structural analysis of the PKR-binding region of HCV 1b samples from patients with chronic hepatitis C and the correlation with IFN-sensitivity. Orvosi Hetilap, 144: 1179-1184.
• National Collaborating Centre for Mental Health (2003) Schizophrenia: Core interventions in the treatment and management of schizophrenia in primary and secondary care. National Clinical Practice Guideline CG1. Gaskell Press: London.
• Simon J (2003) Cost-conscious clinical guidelines: the schizophrenia guideline example. Mental Health Research Review, 9:42-43.
• Simon J, Whittington C, on behalf of the Eating Disorders Guideline Development Group (2003) Cost-effectiveness of antidepressant therapy, cognitive behaviour therapy and their combination for people with bulimia nervosa in the UK. Value in Health, 6(6): A619-A620.  
• National Collaborating Centre for Mental Health (2002) Schizophrenia: Core interventions in the treatment and management of schizophrenia in primary and secondary care. Clinical guideline 1. NICE: London.
• Knapp M, Simon J (2002) Cost implications of schizophrenia in the community. Psychiatry, 1(10): 69-72.
• Knapp M, Simon J, Almond S, Percudani M (2002) Costs of Schizophrenia: A Review. In: Maj M. (ed.) Schizophrenia (2^nd ed). John Wiley & Sons Ltd.: Chichester.
• Gervain J, Czibula A, Kalmar T, Simon J, Papp I, Szabo K. (2002) Mutations of the NS5A domain of HCV subtype 1b and response to interferon therapy in Hungarian patients. Zeitschrift fuer Gastroenterologie, 40: A334.
• Balati B, Jost N, Simon J, Varro A, Papp JGy (2000) Analysis of the electrophysiological effects of ambasilide, a new antiarrhythmic agent in canine isolated ventricular muscle and Purkinje fibres. General Pharmacology, 34(2): 85-93.
• Baláti B, Iost N, Simon J, Varró A, Papp JGy (2000) Az ambasilid, egy antiaritmiás szer elektrofiziológiai hatásainak vizsgálata izolált kutyaszív preparátumokon. Cardiologia Hungarica, Suppl 3: S46.
• Baláti B, Takács J, Iost N, Virág L, Simon J, Varró A, Papp JGy (1999) The role of the slow component of the delayed rectifier potassium current in dog ventricular muscle and Purkinje fibre repolarization. Fundamental and Clinical Pharmacology, 13(Suppl 1): S226.
• Baláti B, Takács J, Iost N, Virág L, Simon J, Varró A, Papp JG. (1999) A "delayed rectifier" káliumáram lassú komponensének szerepe a kutyaszív kamrai munkaizom és Purkinje rostjainak repolarizációjában. Cardiologia Hungarica, Suppl 2: S19.
• Baláti B, Simon J, Varró A, Papp JGy (1998) Cellular electrophysiological effects of chromanol 293B in canine ventricular muscle. Journal of Molecular and Cellular Cardiology, 30: A133.